Iterum Therapeutics plc - ITRM

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$478K
QoQ value delta ($000)
-$299K (-38.48%)
Implied price effect (QoQ)
-50.63%
Shares
Total shares
1,443,878
QoQ shares delta
+285,202 (+24.61%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ITRM)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Apollon Financial, LLC 211 630,250 0.03%
JANE STREET GROUP, LLC 96 289,410 0.0%
Alchemi Wealth, LLC 90 268,886 0.05%
UBS Group AG 40 119,948 0.0%
Krilogy Financial LLC 13 40,000 0.0%
Virtu Financial LLC 7 22,062 0.0%
Ground Swell Capital, LLC 6 20,477 0.01%
Sanctuary Advisors, LLC 6 20,000 0.0%
GEODE CAPITAL MANAGEMENT, LLC 4 12,370 0.0%
SG Americas Securities, LLC 4 12,782 0.0%
MORGAN STANLEY 1 5,713 0.0%
WELLS FARGO & COMPANY/MN 0 85 0.0%
SBI Securities Co., Ltd. 0 16 0.0%
Activest Wealth Management 0 133 0.0%
Medallion Wealth Advisors, LLC 0 1,680 0.0%
Robinswood Financial LLC 0 66 0.0%